As filed with the Securities and Exchange Commission on July 28, 2005
Registration No. 333-
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
COLGATE-PALMOLIVE COMPANY
(Exact Name of Registrant as Specified in Its Charter)
| Delaware (State or Other Jurisdiction of Incorporation) |
No. 13-1815595 (I.R.S. Employer Identification Number) |
300 Park Avenue
New York, New York 10022
(212) 310-2000
(Address, Including Zip Code, and Telephone Number,
Including Area Code, of Registrant's Principal Executive Offices)
ANDREW D. HENDRY
Senior Vice President, General Counsel and Secretary
Colgate-Palmolive Company
300 Park Avenue
New York, New York 10022
(212) 310-2000
(Name, Address, Including Zip Code, and Telephone Number,
Including Area Code, of Agent for Service)
Approximate Date of Commencement Of Proposed Sale to the Public: From time to time after this registration statement becomes effective.
If the only securities being registered on this form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. £
If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. S
If this form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. £
If this form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. £
If delivery of the prospectus is expected to be made pursuant to Rule 434, please check the following box. £
CALCULATION OF REGISTRATION FEE
| Title
of Each Class of Securities to be Registered |
Amount
to be Registered |
Proposed Maximum Offering Price Per Unit(1) |
Proposed Maximum Aggregate Offering Price(1) |
Amount
of Registration Fee |
||||||||||||
|
|
||||||||||||||||
Debt Securities |
$1,500,000,000(2) |
100% |
$1,500,000,000(2) |
$176,550 |
||||||||||||
| (1) | Estimated solely for the purposes of computing the registration fee pursuant to Rule 457(o) of the Securities Act. | |
| (2) | In United States dollars or the equivalent thereof in foreign or composite currencies. Such amount shall be increased, if any Debt Securities are issued at an original issue discount, to such higher principal amount as may be sold for an initial public offering price of up to $1,500,000,000. |
The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.
The Information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted. SUBJECT TO COMPLETION, DATED JULY 28, 2005 PROSPECTUS $1,500,000,000 Debt Securities Neither
the Securities and Exchange Commission nor any state securities commission has
approved or disapproved of these securities or determined if this prospectus
is truthful or complete. Any representation to the contrary is a criminal offense. The date of this prospectus is July ,
2005.
ABOUT THIS PROSPECTUS We will disclose information about the debt securities in this prospectus and prospectus supplements. The term “prospectus supplement” as used in this prospectus includes any pricing supplements relating to particular offerings of debt securities. The relevant prospectus supplements will provide most of the financial and other specific terms of any particular offering of debt securities, many of which are determined at the time of pricing. Because the information provided in the prospectus supplements may also add, delete or change information contained in this prospectus, you should rely on the information in the applicable prospectus supplement or supplements to the extent that it is inconsistent with the information in this prospectus. COLGATE-PALMOLIVE COMPANY Colgate-Palmolive Company, which was founded in 1806 and incorporated under the laws of the State of Delaware in 1923, is a leading consumer products company whose products are marketed in over 200 countries and territories throughout the world. Our principal executive offices are located at 300 Park Avenue, New York, New York 10022 (telephone (212) 310-2000). We manage our business in two distinct product segments: (1) Oral, Personal and Home Care and (2) Pet Nutrition. Colgate is a global leader in Oral Care with the leading toothpaste brand throughout many parts of the world. Our Oral Care products include toothpaste, toothbrushes, tooth whiteners, mouth rinses and dental floss, and pharmaceutical products for dentists and other oral health professionals. Significant recent product launches in this segment include Colgate Max Fresh, Colgate Total Advanced Fresh and Colgate Triple Action toothpastes, and Colgate 360˚ and Massager manual toothbrushes. We are a leader in many segments of the Personal Care market with several products including shower gels, shampoos, conditioners, deodorants and antiperspirants, hand and body lotion and shave products as well as liquid hand soaps where we are the market leader in the U.S. Significant recent product launches in this segment include Mennen Speed Stick 24/7 deodorant, Palmolive Aroma Creme and Palmolive Thermal Spa shower gels. We manufacture and market a wide array of products for Home Care. Major products include Palmolive and Ajax dishwashing liquid, Fabuloso household cleaners and Murphy's oil soap. In our major markets outside the U.S., we are number one in fabric conditioners with leading brands including Suavitel in Latin America and Soupline in Europe. Significant recent product launches in Home Care include Fabuloso Orange Energy All Purpose Cleaner, Palmolive Oxy-Plus dishwashing liquid and Soupline Hearts fabric conditioner. Through our Hill's Pet Nutrition subsidiary, we are the world leader in specialty pet nutrition products for dogs and cats. Hill's markets pet foods primarily under two trademarks: Science Diet, which is sold by authorized pet supply retailers, breeders and veterinarians for every day nutritional needs; and Prescription Diet, a range of therapeutic products to help nutritionally manage disease conditions in dogs and cats. Significant recent product launches and geographic expansions in this segment include Science Diet Canine Senior Large Breed, Science Diet Canine Adult Light Large Breed, Science Diet Feline Hairball canned food and Prescription Diet Feline m/d. Hill's sells its products in 88 countries and leads the specialty pet food segment in North America and Japan. If you want to find more information about our company, please see the sections entitled “Where You Can Find More Information” and “Incorporation of Information We File with the SEC” in this prospectus. USE OF PROCEEDS We intend to use the net proceeds from the sale of the debt securities for general corporate purposes, unless otherwise specified in the applicable prospectus supplement. 2
RATIO OF EARNINGS TO FIXED CHARGES The following table sets forth our historical ratios of earnings to fixed charges for the periods indicated: Ratio
of earnings to fixed charges For the purpose of calculating the ratio of earnings to fixed charges, “earnings” consist of earnings from continuing operations before income taxes and fixed charges, excluding capitalized interest and preferred security dividend requirements. “Fixed charges” consist of interest costs whether expensed or capitalized, amortization of debt expense, discount or premium related to indebtedness and such portion of rental expense that we deem to be representative of interest (33%). DESCRIPTION OF DEBT SECURITIES General We will offer the debt securities described in this prospectus from time to time in one or more distinct series for an aggregate initial public offering price of $1,500,000,000 or its equivalent in foreign currencies or units of two or more currencies, based on the applicable exchange rate at the time of offering, as we shall designate at the time of offering. Unless otherwise specified in the applicable prospectus supplement, the debt securities will be issued under an indenture, dated as of November 15, 1992, as supplemented from time to time, between our company and The Bank of New York, as trustee. A copy of the indenture is filed as an exhibit to the registration statement of which this prospectus is a part. The following summaries of material provisions of the debt securities and of the indenture are not complete and are subject to, and qualified in their entirety by reference to, the provisions of the indenture, including the definitions of terms. The indenture does not limit the amount of debt, secured or unsecured, which we may issue. The debt securities offered by this prospectus are unsecured and rank equally with our other unsecured and unsubordinated indebtedness. Terms of the Debt Securities We may issue the debt securities from time to time, without limitation as to aggregate principal amount and in one or more series. We may issue debt securities upon the satisfaction of conditions, including the delivery to the trustee of a supplemental indenture, or a resolution of our Board of Directors or a committee of our Board of Directors, or a certificate of one of our officers who has been authorized by our Board of Directors to take that kind of action, which fixes or establishes the terms of the debt securities being issued. Any resolution or officer's certificate approving the issuance of any issue of debt securities will include the following terms of that issue of debt securities: • • • 3
• • • • • • • • • • • • • • Please see the applicable prospectus supplement for the terms of the specific debt securities being offered. Prospective purchasers of debt securities should be aware that special U.S. Federal income tax, accounting and other considerations may be applicable to instruments such as the debt securities. The prospectus supplement relating to an issue of debt securities will describe these considerations, if they apply. The provisions of the indenture permit us, without the consent of the holders of any debt securities, to issue additional debt securities with terms different from those of debt securities previously issued and to reopen a previous series of debt securities and issue additional debt securities of that series. The indenture does not contain any provisions which would provide protection to holders of debt securities against a sudden and dramatic decline in credit quality resulting from a takeover, a recapitalization or other highly leveraged transaction involving Colgate. We will pay or deliver principal and any premium, additional amounts and interest in the manner, at the places and subject to the restrictions set forth in the indenture, the debt securities and the applicable prospectus supplement. However, at our option, we may pay any interest by check mailed to the holders of registered debt securities at their registered addresses. Holders may present debt securities for exchange, and registered debt securities for transfer or exchange, in the manner, at the places and subject to the restrictions set forth in the indenture, the debt securities and the prospectus supplement. Holders may transfer debt securities in bearer form for registered debt securities by delivering the bearer debt securities and related 4
coupons, if any, to the office or agency of the registrar for that series of debt securities. If any series of debt securities is issued in global form, the prospectus supplement will describe the circumstances, if any, under which beneficial owners of interests in any global debt security may exchange those interests for definitive debt securities of that same series and of like tenor and principal amount, in any authorized form and denomination. There will be no service charge for any transfer or exchange of debt securities, but we may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection with a transfer or exchange other than certain exchanges not involving any transfer. Merger and Consolidation We may consolidate or merge with or into any other corporation, and we may sell, lease or convey all or substantially all of our assets to any corporation, provided that: Modification and Waiver We and the trustee may modify and amend the indenture with the consent of holders of at least a majority in principal amount or aggregate issue price of each series of debt securities affected. However, the consent of each holder of any debt security affected must be obtained if the amendment or modification: • • • • • The holders of at least a majority in principal amount or aggregate issue price of the outstanding debt securities of any series may, with respect to that series, waive past defaults under the indenture and waive our compliance with certain provisions of the indenture, except as described under “—Events of Default”. Events of Default Except as otherwise provided in the applicable prospectus supplement, each of the following constitutes an event of default with respect to each series of debt securities issued under the indenture: 5
• • • • • If an event of default occurs and is continuing for any series of debt securities, the trustee or the holders of at least 25% in principal amount or aggregate issue price of the outstanding debt securities of that series may declare the principal of all the debt securities of that series, or any lesser amount provided for in the debt securities of that series, due and payable immediately. At any time after such a declaration of acceleration with respect to the debt securities of any series has been made, but before the trustee has obtained a judgment or decree for payment of the money due, the holders of a majority in principal amount or aggregate issue price of the outstanding debt securities of that series by written notice may rescind any declaration of acceleration and its consequences, provided
that all payments and/or deliveries due, other than those due as a result of acceleration, have been made and all other events of default have been remedied or waived. The holders of at least a majority in principal amount or aggregate issue price of the outstanding debt securities of any series may waive an event of default with respect to that series, except a default: • The holders of a majority in principal amount or aggregate issue price of the outstanding debt securities of a series may direct the time, method and place of conducting any proceeding for any remedy available to the trustee or exercising any trust or power conferred on the trustee with respect to debt securities of that series, provided that the direction is not in conflict with any rule of law, the indenture or the debt securities of that series. The trustee must, within 90 days after a default occurs notify the holders of the applicable series of debt securities of the default, unless the default is cured or waived. The trustee may withhold notice of default, except default in payment of principal, any premium, interest or sinking fund payment, if it determines that it is in the interest of
the holders to do so. Before proceeding to exercise any right or power under the indenture at the direction of the holders, the trustee is entitled to receive from those holders reasonable security or indemnity against the costs, expenses and liabilities which might be incurred by it in complying with any such direction. Unless otherwise stated in the prospectus supplement, any series of debt securities issued under the indenture will not have the benefit of any cross-default provisions with other indebtedness of our company. We will be required to furnish to the trustee annually a statement as to our performance of all of our obligations and conditions under the indenture. Limitations Upon Liens The debt securities will not be secured by any mortgage, pledge or other lien. Unless a prospectus supplement with respect to a particular series of debt securities states otherwise, the covenants described below will apply to each series of debt securities. 6
We covenant in the indenture not to create or suffer to exist, or permit any of our Principal Domestic Subsidiaries to create or suffer to exist, any Lien on any Restricted Property, whether owned on the date of the indenture or thereafter acquired, without making effective provision (and we covenant and agree in the indenture that we will make or cause to be made effective provision) whereby the debt securities shall be directly secured by such Lien equally and ratably with (or prior to) all other indebtedness secured by such Lien as long as such other indebtedness shall be so secured; provided, however, that there shall be excluded from the foregoing restrictions: • • • • • • • 7
• • “Code” means the Internal Revenue Code of 1986, as amended. “Consolidated Net Tangible Assets” means the aggregate amount of assets (less applicable reserves and other properly deductible items) after deducting therefrom (1) all current liabilities and (2) all goodwill, trade names, trademarks, patents, unamortized debt discount and expense and other like intangibles of ours and our consolidated subsidiaries, all as set forth on the most recent balance sheet of ours and our consolidated subsidiaries prepared in accordance with generally accepted accounting principles as practiced in the United States. “Debt” means (1) indebtedness for borrowed money, (2) obligations evidenced by bonds, debentures, notes or other similar instruments, (3) obligations to pay the deferred purchase price of property or services (other than accounts payable in the ordinary course of business), (4) obligations as a lessee under leases which shall have been or should be, in accordance with generally accepted accounting principles, recorded as capital leases, and (5) obligations under direct or indirect guaranties in respect of, and obligations (contingent or otherwise) to purchase or otherwise acquire, or otherwise to assure a creditor against loss in respect of, indebtedness or obligations of others of the kinds referred to in clauses (1) through (4) above. “Domestic Subsidiary” means any Subsidiary a majority of the business of which is conducted within the United States of America, or a majority of the properties and assets of which are located within the United States of America, except (1) any Subsidiary whose assets consist substantially of the securities of Subsidiaries which are not Domestic Subsidiaries, (2) any Subsidiary which is a FSC as defined in Section 922 of the Code and (3) any Subsidiary for any period during which an election under Section 936 of the Code applies to such Subsidiary. “Instruments” of any corporation means and includes (1) all capital stock of all classes of and all other equity interests in such corporation and all rights, options or warrants to acquire the same, and (2) all promissory notes, debentures, bonds and other evidences of Debt of such corporation. “Lien” means any mortgage, lien, pledge, security interest, encumbrance or charge of any kind, any conditional sale or other title retention agreement or any lease in the nature thereof, provided that the term “Lien” shall not include any lease involved in a sale and lease-back transaction. “Major Domestic Manufacturing Property” means any Principal Domestic Manufacturing Property the net depreciated book value of which on the date as of which the determination is made exceeds 3% of the Consolidated Net Tangible Assets. “Principal Domestic Manufacturing Property” means any building, structure or facility (including the land on which it is located and the improvements and fixtures constituting a part thereof) used primarily for manufacturing or processing which is owned or leased by us or any of our Subsidiaries, is located in the United States of America and the net depreciated book value of which on the date as of which the determination is made exceeds 1% of Consolidated Net 8
Tangible Assets, except any such building, structure or facility which our Board of Directors by resolution declares is not of material importance to the total business conducted by us and our Subsidiaries as an entirety. “Principal Domestic Subsidiary” means (1) each Subsidiary which owns or leases a Principal Domestic Manufacturing Property, (2) each Domestic Subsidiary the consolidated net worth of which exceeds 3% of Consolidated Net Tangible Assets (as set forth in the most recent financial statements delivered pursuant to the indenture) and (3) each Domestic Subsidiary of each Subsidiary referred to in the foregoing clause (1) or (2) except any such Subsidiary the accounts receivable and inventories of which have an aggregate net book value of less than $5,000,000. “Restricted Property” means and includes (1) all Principal Domestic Manufacturing Properties, (2) all Instruments of all Principal Domestic Subsidiaries and (3) all inventories and accounts receivable of ours and our Principal Domestic Subsidiaries. “Subsidiary” means any Corporation of which at the time of determination we or one or more of our Subsidiaries owns or controls directly or indirectly more than 50% of the shares of Voting Stock. “Voting Stock” means stock of a Corporation of the class or classes having general voting power under ordinary circumstances to elect at least a majority of the board of directors, managers or trustees of such Corporation, provided that, for this purpose, stock which carries only the right to vote conditionally on the happening of an event shall not be considered voting stock whether or not such event shall have happened. Other capitalized terms used but not defined in this prospectus shall have the meaning given those terms in the indenture. Legal Defeasance and Covenant Defeasance We
at any time may terminate as to a series of debt securities all of our obligations
(except for certain obligations regarding the defeasance trust and obligations
to register the transfer or exchange of a debt security, to replace destroyed,
lost or stolen debt securities and any related coupons and to maintain agencies
with respect to the debt securities) arising under the indenture and the debt
securities and coupons of that series. This option of ours is called a “legal
defeasance.” We at any time may terminate as to a series of debt securities,
among other obligations, our obligations arising under the covenant described
under “Limitations Upon Liens” above. This option of ours is called
a “covenant defeasance”. We may exercise our legal defeasance option with respect to a series of debt securities even if we have previously exercised our covenant defeasance option in regard to that series of debt securities. If we exercise our legal defeasance option with respect to a series of debt securities, that series may not be accelerated because of an Event of Default. If we exercise our covenant defeasance option with respect to a series of debt securities, that series may not be accelerated on the basis of breaches of the defeased covenant. To exercise either option as to a series of debt securities, we must deposit in trust with the trustee cash or United States government obligations sufficient to pay the principal of, premium, if any, and interest on the debt securities of that series at their maturity or redemption and must comply with other specified conditions. In particular, we must obtain an opinion of tax counsel that the defeasance will not result in recognition for United States Federal income tax purposes of any gain or loss to holders of the series of debt securities. The opinion of tax counsel, in the case of legal defeasance, must refer to and be based upon a ruling of the Internal Revenue Service or a change in applicable United States Federal income tax law occurring after the date of the indenture. Concerning the Trustee The Bank of New York serves as trustee under the Indenture and is the security registrar and paying agent with respect to the debt securities. The indenture provides that, except during 9
the continuance of an Event of Default, the trustee will perform only such duties as are specifically set forth in the indenture. During the existence of an Event of Default, the trustee will exercise such rights and powers vested in it under the indenture and use the same degree of care and skill in its exercise as a prudent person would exercise under the circumstances in the conduct of such person's own affairs. The indenture contains certain limitations on the right of the trustee, should it become a creditor of ours, to obtain payment of claims in certain cases, or to realize on certain property received in respect of any such claim as security or otherwise. The trustee is permitted to engage in other transactions with us; provided, however, that if the trustee acquires any conflicting interest it must eliminate such conflict or resign. The trustee's principal office is located at One Wall Street, New York, New York 10286. We have banking relationships with The Bank of New York and certain of its affiliates. Richard J. Kogan, one of our directors, is also a director of The Bank of New York Company, Inc., the parent of the trustee. Governing Law The indenture and the debt securities will be governed by, and construed in accordance with, the laws of the State of New York. PLAN OF DISTRIBUTION We may sell debt securities: • The prospectus supplement with respect to the particular series of debt securities being offered will describe the terms of the offering of that series, including the name or names of any agents or underwriters, the public offering or purchase price, the proceeds to us from the offering, any discounts and commissions to be allowed or paid to the agents or underwriters, all other items constituting underwriting compensation, any discounts and commissions to be allowed or paid to dealers, any initial public offering price and any exchanges on which the debt securities may be listed. Underwriters, dealers and agents that participate in the distribution of the debt securities may be deemed to be underwriters, and any discounts or commissions received by them from us and any profit on the resale of
the debt securities by them may be deemed to be underwriting discounts and commissions, under the Securities Act of 1933, as amended. Under certain circumstances, we may repurchase debt securities and reoffer them to the public as set forth above. We may also arrange for repurchases and resales of the debt securities by dealers. No particular offering of debt securities will have an established trading market when issued. Unless specified in the applicable prospectus supplement, we will not list the notes on any securities exchange. The underwriters may from time to time purchase and sell notes in the secondary market, but they are not obligated to do so, and there can be no assurance that there will be a secondary market for the notes or liquidity in the secondary market if one develops. In addition, the underwriters may discontinue any market-making activity at any time. To facilitate a debt securities offering, any underwriter may engage in over-allotment, stabilizing transactions, short covering transactions and penalty bids in accordance with Regulation M under the Securities Exchange Act of 1934, as amended. 10
• • • Those activities may cause the price of the securities to be higher than it would otherwise be. If commenced, the underwriters may discontinue those activities at any time. If so indicated in the prospectus supplement, we will authorize underwriters to solicit offers by certain institutions to purchase debt securities from us pursuant to delayed delivery contracts providing for payment and delivery on the date stated in the prospectus supplement. Each contract will be for an amount not less than, and, unless we otherwise agree, the aggregate principal amount of debt securities sold pursuant to the contracts shall not be more than, the respective amounts stated in the prospectus supplement. Institutions with whom the contracts, when authorized, may be made include commercial and savings banks, insurance companies, pension funds, investment companies, educational and charitable institutions, and other institutions, but shall in all cases be subject to our approval.
Delayed delivery contracts will not be subject to any conditions except that the purchase by an institution of the debt securities covered under any such contract shall not at the time of delivery be prohibited under the laws of any jurisdiction in the United States to which that institution is subject. We
have agreed to indemnify the agents and the underwriters against certain civil
liabilities, including liabilities under the Securities Act of 1933, or to contribute
to payments the agents or the underwriters may be required to make in connection
with those liabilities. Agents, underwriters and dealers may be customers of
ours, engage in transactions with us, or perform services for us in the ordinary
course of business. WHERE YOU CAN FIND MORE INFORMATION We
file annual, quarterly and current reports, proxy statements and other information
with the SEC. Our SEC filings are available over the Internet on the SEC's
web site at http://www.sec.gov and on our web site at http://www.colgate.com.
You may also read and copy any document we file by visiting the SEC's public
reference rooms at 100 F Street, N.E., Washington, D.C. 20549. You may obtain
information on the operation of the Public Reference Room by calling the SEC
at 1-800-SEC-0330. Copies of these materials also can be obtained at prescribed
rates from the SEC, Public Reference Section, 100 F Street, N.E., Washington,
D.C. 20549. Our common stock is listed and traded on the New York Stock Exchange.
You may also inspect the information we file with the SEC at the NYSE's offices
at 20 Broad Street, New York, New York 10005. Information about us is also available
at our web site at http://www.colgate.com. However, the information on our web
site is not a part of this prospectus. We have filed a registration statement on Form S-3 with the SEC covering the debt securities. For further information on us and the debt securities, you should refer to our registration statement and its exhibits. This prospectus summarizes certain provisions of contracts and other documents that we refer you to. Because the prospectus may not contain all the information that you may find important, you should review the full text of these documents. We have included copies of these documents as exhibits to our registration statement of which this prospectus is a part. INCORPORATION OF INFORMATION WE FILE WITH THE SEC The SEC allows us to incorporate by reference the information we file with them, which means: 11
• • We incorporate by reference the documents listed below which we filed with the SEC under the Securities Exchange Act of 1934 (except that we do not incorporate by reference any portion of a document that is deemed, under SEC rules, not to be filed): • • We also incorporate by reference each of the following documents that we will file with the SEC after the date of this prospectus until this offering is completed: • You should rely only on information contained or incorporated by reference in this prospectus. Neither we nor any agent or underwriter acting on our behalf has authorized any other person to provide you with different or additional information. If anyone provides you with different or inconsistent information, you should not rely on it. Neither we nor any agent or underwriter acting on our behalf is making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should assume that the information appearing in this prospectus is accurate as of the date of this prospectus only. Our business, financial condition and results of operations may have changed since that date. You
may request a copy of any filings referred to above (excluding exhibits that
are not specifically incorporated by reference therein), at no cost, by contacting
us at the following address: Investor Relations, Colgate-Palmolive Company,
300 Park Avenue, New York, New York 10022-7499, Telephone: (212) 310-2000,
E-mail: Investor_Relations@colpal.com. EXPERTS The consolidated financial statements and management's assessment of the effectiveness of internal control over financial reporting (which is included in Management's Report on Internal Control over Financial Reporting) incorporated in this prospectus by reference from the Annual Report on Form 10-K of Colgate-Palmolive Company and its subsidiaries for the year ended December 31, 2004 have been so incorporated in reliance on the report of PricewaterhouseCoopers LLP, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting. 12
PART II. Item 14. Other Expenses of Issuance and Distribution* The following table sets forth the expenses in connection with the issuance and distribution of the securities being registered, other than underwriting discounts and commissions. All of the amounts shown are estimates, except the registration fee. Securities
and Exchange Commission Registration Fee Legal
Fees and Expenses Services
of Independent Registered Public Accounting Firm Printing
Expenses, including Engraving Trustee's
Fees and Expenses Miscellaneous
Expenses Total Item 15. Indemnification of Directors and Officers Reference is made to Section 145 of the General Corporation Law of the State of Delaware (the “GCL”), which provides for indemnification of directors, officers and other employees in certain circumstances, and to Section 102(b)(7) of the GCL, which provides for the elimination or limitation of the personal liability for monetary damages of directors under certain circumstances. Article Tenth of the Restated Certificate of Incorporation of the Company, as amended, eliminates the personal liability for monetary damages of directors under certain circumstances and provides indemnification to directors, officers and other employees of the Company to the fullest extent permitted by the GCL. The Company has also executed indemnification agreements with the directors, officers and certain
other employees of the Company. Such indemnification agreements contain provisions which purport to provide indemnification, where not limited by applicable law, for amounts paid by such individuals in settlement of shareholder derivative actions. Additionally, the Company maintains customary directors' and officers' liability insurance. Item 16. Exhibits The exhibits to this registration statement are listed in the exhibit index, which appears elsewhere in this registration statement and is incorporated herein by reference. Item 17. Undertakings (a) The undersigned registrant hereby undertakes: II-1
(b) The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant's annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. (c) Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the provisions referred to in Item 15 of this registration statement, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person
in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of such issue. (d) The undersigned registrant hereby undertakes that: II-2
SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in The City of New York, State of New York, on July 28, 2005. Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated. II-3
INDEX TO EXHIBITS 1.1 4.1 4.2 4.3 5.1 12.1 23.1 23.2 24.1 25.1 EXHIBIT 12.1 COLGATE-PALMOLIVE
COMPANY Earnings: Income
before income taxes Add: Interest
on indebtedness and amortization of debt expense Portion
of rents representative of interest factor Interest
on ESOP notes in excess of dividends on Preference Stock Loss
on equity investments Less: Gain
on equity investments Income
as adjusted Fixed
Charges: Interest
on indebtedness and amortization of debt expense Portion
of rents representative of interest factor Interest
on ESOP notes in excess of dividends on Preference Stock Capitalized
interest Total
fixed charges Ratio
of earnings to fixed charges EXHIBIT 23.2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in this Registration Statement on Form S-3 of our report dated February 23, 2005 relating to the consolidated financial statements, management's assessment of the effectiveness of internal control over financial reporting and the effectiveness of internal control over financial reporting, which appears in Colgate-Palmolive Company's Annual Report on Form 10-K for the year ended December 31, 2004. We also consent to the incorporation by reference of our report dated February 23, 2005 relating to the financial statement schedule, which appears in such Annual Report on Form 10-K. We also consent to the reference to us under the heading “Experts” in such Registration Statement. New York, New York EXHIBIT 24.1 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS: I, Jill K. Conway, do hereby make, constitute and appoint Reuben Mark, Stephen C. Patrick, Dennis J. Hickey and Andrew D. Hendry, and each of them, as my attorneys-in-fact and agents with full power of substitution for me and in my name, place and stead, in any and all capacities, to execute for me and on my behalf a Registration Statement of Colgate-Palmolive Company (the “Company”) on Form S-3, or other appropriate forms relating to the issuance of up to $1,500,000,000 aggregate principal amount of Medium-Term Notes and any and all amendments (including post-effective amendments) to the foregoing Registration Statement and any other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents,
and each of them, full power and authority to do and perform each and every act and thing necessary and proper to be done in and about the premises, as fully to all intents and purposes as I might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents and/or any of them, may lawfully do or cause to be done by virtue hereof. In witness whereof, I have executed this Power of Attorney this 26th day of July, 2005.
POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS: I, Ronald E. Ferguson, do hereby make, constitute and appoint Reuben Mark, Stephen C. Patrick, Dennis J. Hickey and Andrew D. Hendry, and each of them, as my attorneys-in-fact and agents with full power of substitution for me and in my name, place and stead, in any and all capacities, to execute for me and on my behalf a Registration Statement of Colgate-Palmolive Company (the “Company”) on Form S-3, or other appropriate forms relating to the issuance of up to $1,500,000,000 aggregate principal amount of Medium-Term Notes and any and all amendments (including post-effective amendments) to the foregoing Registration Statement and any other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact
and agents, and each of them, full power and authority to do and perform each and every act and thing necessary and proper to be done in and about the premises, as fully to all intents and purposes as I might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents and/or any of them, may lawfully do or cause to be done by virtue hereof. In witness whereof, I have executed this Power of Attorney this 26th day of July, 2005.
POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS: I, Ellen M. Hancock, do hereby make, constitute and appoint Reuben Mark, Stephen C. Patrick, Dennis J. Hickey and Andrew D. Hendry, and each of them, as my attorneys-in-fact and agents with full power of substitution for me and in my name, place and stead, in any and all capacities, to execute for me and on my behalf a Registration Statement of Colgate-Palmolive Company (the “Company”) on Form S-3, or other appropriate forms relating to the issuance of up to $1,500,000,000 aggregate principal amount of Medium-Term Notes and any and all amendments (including post-effective amendments) to the foregoing Registration Statement and any other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact
and agents, and each of them, full power and authority to do and perform each and every act and thing necessary and proper to be done in and about the premises, as fully to all intents and purposes as I might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents and/or any of them, may lawfully do or cause to be done by virtue hereof. In witness whereof, I have executed this Power of Attorney this 26th day of July, 2005.
POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS: I, David W. Johnson, do hereby make, constitute and appoint Reuben Mark, Stephen C. Patrick, Dennis J. Hickey and Andrew D. Hendry, and each of them, as my attorneys-in-fact and agents with full power of substitution for me and in my name, place and stead, in any and all capacities, to execute for me and on my behalf a Registration Statement of Colgate-Palmolive Company (the “Company”) on Form S-3, or other appropriate forms relating to the issuance of up to $1,500,000,000 aggregate principal amount of Medium-Term Notes and any and all amendments (including post-effective amendments) to the foregoing Registration Statement and any other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact
and agents, and each of them, full power and authority to do and perform each and every act and thing necessary and proper to be done in and about the premises, as fully to all intents and purposes as I might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents and/or any of them, may lawfully do or cause to be done by virtue hereof. In witness whereof, I have executed this Power of Attorney this 26th day of July, 2005.
POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS: I, Richard J. Kogan, do hereby make, constitute and appoint Reuben Mark, Stephen C. Patrick, Dennis J. Hickey and Andrew D. Hendry, and each of them, as my attorneys-in-fact and agents with full power of substitution for me and in my name, place and stead, in any and all capacities, to execute for me and on my behalf a Registration Statement of Colgate-Palmolive Company (the “Company”) on Form S-3, or other appropriate forms relating to the issuance of up to $1,500,000,000 aggregate principal amount of Medium-Term Notes and any and all amendments (including post-effective amendments) to the foregoing Registration Statement and any other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact
and agents, and each of them, full power and authority to do and perform each and every act and thing necessary and proper to be done in and about the premises, as fully to all intents and purposes as I might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents and/or any of them, may lawfully do or cause to be done by virtue hereof. In witness whereof, I have executed this Power of Attorney this 26th day of July, 2005.
POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS: I, Delano E. Lewis, do hereby make, constitute and appoint Reuben Mark, Stephen C. Patrick, Dennis J. Hickey and Andrew D. Hendry, and each of them, as my attorneys-in-fact and agents with full power of substitution for me and in my name, place and stead, in any and all capacities, to execute for me and on my behalf a Registration Statement of Colgate-Palmolive Company (the “Company”) on Form S-3, or other appropriate forms relating to the issuance of up to $1,500,000,000 aggregate principal amount of Medium-Term Notes and any and all amendments (including post-effective amendments) to the foregoing Registration Statement and any other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact
and agents, and each of them, full power and authority to do and perform each and every act and thing necessary and proper to be done in and about the premises, as fully to all intents and purposes as I might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents and/or any of them, may lawfully do or cause to be done by virtue hereof. In witness whereof, I have executed this Power of Attorney this 26th day of July, 2005.
POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS: I, Elizabeth A. Monrad, do hereby make, constitute and appoint Reuben Mark, Stephen C. Patrick, Dennis J. Hickey and Andrew D. Hendry, and each of them, as my attorneys-in-fact and agents with full power of substitution for me and in my name, place and stead, in any and all capacities, to execute for me and on my behalf a Registration Statement of Colgate-Palmolive Company (the “Company”) on Form S-3, or other appropriate forms relating to the issuance of up to $1,500,000,000 aggregate principal amount of Medium-Term Notes and any and all amendments (including post-effective amendments) to the foregoing Registration Statement and any other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact
and agents, and each of them, full power and authority to do and perform each and every act and thing necessary and proper to be done in and about the premises, as fully to all intents and purposes as I might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents and/or any of them, may lawfully do or cause to be done by virtue hereof. In witness whereof, I have executed this Power of Attorney this 26th day of July, 2005.
POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS: I, Howard B. Wentz, Jr., do hereby make, constitute and appoint Reuben Mark, Stephen C. Patrick, Dennis J. Hickey and Andrew D. Hendry, and each of them, as my attorneys-in-fact and agents with full power of substitution for me and in my name, place and stead, in any and all capacities, to execute for me and on my behalf a Registration Statement of Colgate-Palmolive Company (the “Company”) on Form S-3, or other appropriate forms relating to the issuance of up to $1,500,000,000 aggregate principal amount of Medium-Term Notes and any and all amendments (including post-effective amendments) to the foregoing Registration Statement and any other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact
and agents, and each of them, full power and authority to do and perform each and every act and thing necessary and proper to be done in and about the premises, as fully to all intents and purposes as I might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents and/or any of them, may lawfully do or cause to be done by virtue hereof. In witness whereof, I have executed this Power of Attorney this 26th day of July, 2005. EXHIBIT 25.1 FORM T-1 SECURITIES AND EXCHANGE COMMISSION STATEMENT OF ELIGIBILITY CHECK IF AN APPLICATION TO DETERMINE THE BANK OF NEW YORK COLGATE-PALMOLIVE COMPANY Debt Securities
SIGNATURE Pursuant to the requirements of the Act, the Trustee, The Bank of New York, a corporation organized and existing under the laws of the State of New York, has duly caused this statement of eligibility to be signed on its behalf by the undersigned, thereunto duly authorized, all in The City of New York, and State of New York, on the 26th day of July, 2005.
EXHIBIT 7 Consolidated Report of Condition of a member of the Federal Reserve System, at the close of business March 31, 2005, published in accordance with a call made by the Federal Reserve Bank of this District pursuant to the provisions of the Federal Reserve Act. ASSETS Cash
and balances due from depository institutions: Noninterest-bearing
balances and currency and coin Interest-bearing
balances Securities: Held-to-maturity
securities Available-for-sale
securities Federal
funds sold and securities purchased under agreements to resell Federal
funds sold in domestic offices Securities
purchased under agreements to resell Loans
and lease financing receivables: Loans
and leases held for sale Loans
and leases, net of unearned income LESS:
Allowance for loan and lease losses Loans
and leases, net of unearned income and allowance Trading
Assets Premises
and fixed assets (including capitalized leases) Other
real estate owned Investments
in unconsolidated subsidiaries and associated companies Customers'
liability to this bank on acceptances outstanding Intangible
assets: Goodwill Other
intangible assets Other
assets Total
assets LIABILITIES Deposits: In
domestic offices Noninterest-bearing Interest-bearing In
foreign offices, Edge and Agreement subsidiaries, and IBFs Noninterest-bearing Interest-bearing Federal
funds purchased and securities sold under agreements to repurchase
Federal funds purchased in domestic offices Securities
sold under agreements to repurchase Trading
liabilities Other
borrowed money: Not
applicable Bank's
liability on acceptances executed and outstanding Subordinated
notes and debentures Other
liabilities Total
liabilities Minority
interest in consolidated subsidiaries EQUITY
CAPITAL Perpetual
preferred stock and related surplus Common
stock Surplus
(exclude all surplus related to preferred stock) Retained
earnings Accumulated
other comprehensive income Other
equity capital components Total
equity capital Total
liabilities, minority interest, and equity capital
I, Thomas J. Mastro, Senior Vice President and Comptroller of the above-named bank do hereby declare that this Report of Condition is true and correct to the best of my knowledge and belief. We, the undersigned directors, attest to the correctness of this statement of resources and liabilities. We declare that it has been examined by us, and to the best of our knowledge and belief has been prepared in conformance with the instructions and is true and correct.
•
By this prospectus, we may offer from time
to time up to $1,500,000,000 of our debt
securities.
•
You should read this prospectus and the
prospectus supplement relating to the
specific offering of securities carefully
before you invest.
•
When we offer debt securities, we will
provide you with a prospectus supplement
describing the terms of the specific issue of
securities including the offering price of the
securities.
Three
Months
Ended
March 31,
Year
Ended December 31,
2005
2004
2003
2002
2001
2000
•
the
aggregate principal amount;
the
stated maturity date;
the
date or dates on which we will pay principal, if other than at maturity,
or the method we will use to determine these dates;
if
the amount of payments of principal (and premium, if any) or interest may
be determined with reference to an index, formula or other method, the manner
in which such amounts will be determined;
whether
and how the principal amount will be determined, whether by reference to
an index, formula or other method;
the
rate or rates (or manner of calculating the rate or rates) at which the
debt securities will bear interest, if any, and the date or dates from which
any interest will accrue;
the
interest payment dates and regular record dates for any interest payable;
if
in addition to or other than the Borough of Manhattan, The City of New York,
the place or places where the principal (and premium, if any) and interest,
if any, will be payable, and where the debt securities may be delivered
for registration, transfer or exchange;
any
provisions for redemption of the debt securities, the redemption price or
prices and any remarketing arrangements;
any
mandatory redemption or sinking fund or analogous provisions;
whether
the debt securities are denominated or payable in United States dollars
or in one or more currencies or units of two or more currencies;
the
form in which we will issue the debt securities, whether registered, bearer
or both, and any restrictions applicable to the exchange of one form for
another and/or to the offer, sale and delivery of the debt securities in
either form;
whether
and under what circumstances we will pay additional amounts under any debt
securities held by a person who is not a U.S. person for specified taxes,
assessments or other governmental charges and whether we have the option
to redeem the affected debt securities rather than pay any such additional
amounts;
whether
the debt securities are to be issued in global form and if so, the depositary
for the global securities;
the
title of the debt securities and the series of which the debt securities
are a part;
the
minimum denominations in which any debt securities will be issuable if other
than denominations of $1,000 and any integral multiple thereof;
any
additional covenants or events of default applicable to our company; and
any
other terms of the debt securities which are not inconsistent with the provisions
of the indenture.
•
the resulting corporation, if other than Colgate, is a corporation organized and existing under the laws of the United States of America or any U.S. state or the District of Columbia and assumes all of our obligations to:
(1)
pay
or deliver the principal of or any premium, interest or additional amounts
on the debt securities; and
(2)
perform
and observe all of our other obligations under the indenture, and
•
we
or any successor corporation, as the case may be, are not, immediately after
any such consolidation, merger or sale of assets, in default under the indenture.
•
changes
the stated maturity of the principal of, or any premium or installment of
interest or additional amounts on, any debt security;
reduces
the principal amount due and payable at maturity or upon acceleration of
maturity of, or the rate of interest or additional amounts payable on, or
any premium payable on redemption or otherwise on, any debt security;
adversely
affects any right of repayment at the option of the holders;
changes
the place of delivery of, or currency of, the payment of principal or any
premium, interest or additional amounts on any debt security or impairs
the right to institute suit for the enforcement of any such payment or delivery;
reduces
the percentage in principal amount or aggregate issue price of the outstanding
debt securities of any series, the consent of whose holders is required
to modify or amend the indenture; or
modifies
the foregoing requirements or reduces the percentage to less than a majority
in principal amount or aggregate issue price of outstanding debt securities
necessary to waive certain past defaults by Colgate under the indenture.
•
default
in the payment of any interest or additional amounts when due and continuing
for 30 days;
default
in the payment of any principal or premium when due and payable at maturity;
default
in the payment of any sinking fund payment when due;
default
in the performance, or breach, of any other obligation of ours under the
indenture, or under provisions of a series of debt securities that are applicable
to all series of debt securities, and continuance of the default for 60
days after we are given written notice of the default as provided in the
indenture;
specified
events of bankruptcy, insolvency or reorganization of Colgate; and
any
other event of default with respect to debt securities of that series.
•
in
the payment of any amounts due and payable or deliverable under the debt
securities of that series; or
in
respect of an obligation of ours contained in, or a provision of, the indenture
which cannot be modified under the terms of the indenture without the consent
of each holder of outstanding debt securities affected.
•
Liens
securing Debt not exceeding $10,000,000 which are existing on the date of
the indenture on Restricted Property; and, if any property owned or leased
as of the date of the indenture by us or one of our Principal Domestic Subsidiaries
at any time thereafter becomes a Principal Domestic Manufacturing Property,
any Liens existing on the date of the indenture on such property securing
the Debt secured or evidenced thereby on the date of the indenture;
Liens
on Restricted Property of a Principal Domestic Subsidiary as a security
for Debt of such Subsidiary to us or to another Principal Domestic Subsidiary;
in
the case of any corporation which becomes a Principal Domestic Subsidiary
after the date of the indenture, Liens on Restricted Property of such Principal
Domestic Subsidiary which are in existence at the time it becomes a Principal
Domestic Subsidiary and which were not incurred in contemplation of it becoming
a Principal Domestic Subsidiary;
any
Lien existing prior to the time of acquisition of any Principal Domestic
Manufacturing Property acquired by us or one of our Principal Domestic Subsidiaries
after the date of the indenture through purchase, merger, consolidation
or otherwise;
any
Lien on any Principal Domestic Manufacturing Property (other than a Major
Domestic Manufacturing Property) acquired or constructed by our company
or a Principal Domestic Subsidiary after the date of the indenture which
is placed on such Property at the time of or within 180 days after the acquisition
thereof or prior to, at the time of or within 180 days after completion
of construction thereof to secure all or a portion of the price of such
acquisition or construction or funds borrowed to pay all or a portion of
the price of such acquisition or construction;
extensions,
renewals or replacements of any Lien referred to in the first, third, fourth
or fifth bullet points above to the extent that the principal amount of
the Debt secured or evidenced thereby is not increased, provided
that the Lien
is not extended to any other Restricted Property;
Liens
imposed by law, such as carriers', warehousemen's, mechanics',
materialmen's, vendors' and landlords' liens, and liens arising
out of judgments or awards against us or any of our Principal Domestic Subsidiaries
with respect to which we or such Subsidiary at the time shall currently
be prosecuting an appeal or proceedings for review and with respect to which
it shall have secured a stay of execution pending such appeal or proceedings
for review;
Liens
securing the payment of taxes, assessments and governmental charges or levies,
either (1) not delinquent or (2) being contested in good faith
by appropriate legal or administrative proceedings and as to which we or
a Principal Domestic Subsidiary, as the case may be, to the extent required
by generally accepted accounting principles applied on a consistent basis,
shall have set aside on its books adequate reserves;
minor
survey exceptions, minor encumbrances, easements or reservations of, or
rights of others for, rights of way, sewers, electric lines, telegraph and
telephone lines and other similar purposes and zoning or other restrictions
as to the use of any Principal Domestic Manufacturing Property, which exceptions,
encumbrances, easements, reservations, rights and restrictions do not, in
our opinion, in the aggregate materially detract from the value of such
Principal Domestic Manufacturing Property or materially impair its use in
the operation of our business and that of our Principal Domestic Subsidiaries;
and
any
Lien on Restricted Property not referred to above if, at the time such Lien
is created, incurred, assumed or suffered to be created, incurred or assumed,
and after giving effect thereto and to the Debt secured or evidenced thereby,
the aggregate amount of all our outstanding Debt together with that of our
Principal Domestic Subsidiaries secured or evidenced by Liens on Restricted
Property which are not referred to above and which do not equally and ratably
secure the debt securities, shall not exceed 15% of Consolidated Net Tangible
Assets.
•
to
the public through underwriters acting individually or through a group of
underwriters which may be managed or co-managed by one or more underwriters
designated by us,
•
through
agents or dealers,
•
directly
to one or more other purchasers, or
by
any combination of these methods of sale.
•
Over-allotment involves sales in excess of the offering size, which creates a short position.
Stabilizing
transactions permit bids to purchase the underlying security so long as
the stabilizing bids do not exceed a specified maximum.
Short
covering transactions involve purchases of the securities in the open market
after the distribution is completed to cover short positions.
Penalty
bids permit the underwriters to reclaim a selling concession from a dealer
when the securities originally sold by the dealer are purchased in a covering
transaction to cover short positions.
•
incorporated
documents are considered part of this prospectus;
we
can disclose important information to you by referring you to those documents;
and
information
that we file with the SEC will automatically update and, to the extent inconsistent,
supersede this prospectus and previously incorporated information.
•
annual
report on Form 10-K for the year ended December 31, 2004;
quarterly
report on Form 10-Q for the quarter ended March 31, 2005; and
current
reports on Form 8-K dated January 27, 2005, March 10, 2005, March 11,
2005, May 6, 2005, May 20, 2005, June 10, 2005, June 15,
2005 and July 8, 2005.
•
all
documents filed under Sections 13(a), 13(c), 14 or 15(d) of the Exchange
Act, including definitive proxy or information statements filed under Section 14
of the Exchange Act in connection with any subsequent stockholders'
meeting (other than information in the documents that is deemed to have
been furnished and not filed); and
any
reports filed under Section 15(d) of the Exchange Act.
INFORMATION NOT REQUIRED IN PROSPECTUS
$ 176,550
150,000
25,000
100,000
15,000
8,450
$ 475,000
* Estimated assuming one Prospectus Supplement
(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:
(i)
To include any prospectus required by section 10(a)(3) of the Securities
Act of 1933;
(ii)
To reflect in the prospectus any facts or events arising after the effective
date of the registration statement (or the most recent post-effective amendment
thereof) which, individually or in the aggregate, represent a fundamental
change in the information set forth in the registration statement. Notwithstanding
the foregoing, any increase or decrease in volume of securities offered
(if the total dollar value of the securities offered would not exceed that
which was registered) and any deviation from the low or high end of the
estimated maximum offering range may be reflected in the form of prospectus
filed with the Commission pursuant to Rule 424(b) if, in the aggregate,
the changes in volume and price represent no more than a 20 percent change
in the maximum aggregate
offering price set forth
in the “Calculation of the Registration Fee” table in the effective
registration statement;
(iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;
provided,
however, that paragraphs
(1)(i) and (1)(ii) do not apply if the registration statement is on Form S-3,
and the information required to be included in a post-effective amendment by
those paragraphs is contained in periodic reports filed with or furnished to
the Commission by the registrant pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934 that are incorporated by reference in the registration
statement.
(2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
(1) For purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.
(2) For the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
COLGATE-PALMOLIVE
COMPANY
By: /s/
Reuben Mark
Reuben
Mark
Chairman
of the Board, Chief
Executive
Officer and Director
Signature
Title
Date
Principal
Executive Officer and Director:
/s/
Reuben Mark
Reuben
Mark
Chairman
of the Board, Chief
Executive Officer and Director
July 28,
2005
Principal
Financial Officer:
/s/
Stephen C. Patrick
Stephen
C. Patrick
Chief
Financial Officer
July 28,
2005
Principal
Accounting Officer:
/s/
Dennis J. Hickey
Dennis
J. Hickey
Vice
President, Corporate Controller
July 28,
2005
Directors:
*
Jill K.
Conway
Director
July 28,
2005
*
Ronald
E. Ferguson
Director
July 28,
2005
*
Ellen M.
Hancock
Director
July 28,
2005
*
David W.
Johnson
Director
July 28,
2005
*
Richard
J. Kogan
Director
July 28,
2005
*
Delano
E. Lewis
Director
July 28,
2005
*
Elizabeth
A. Monrad
Director
July 28,
2005
*
Howard
B. Wentz, Jr.
Director
July 28,
2005
Directors:
*By
/s/ Andrew D. Hendry
Andrew
D. Hendry
Attorney-in-Fact
Form
of Distribution Agreement*
Indenture,
dated as of November 15, 1992, between the Company and The Bank of New York
as Trustee (incorporated by reference from Exhibit 4.1 to the Company's
Form S-3 Registration Statement and Post-Effective Amendment No. 1
filed on June 26, 1992, Registration No. 33-48840)
Form
of Fixed Rate Note*
Form
of Floating Rate Note*
Opinion
of Sidley Austin Brown & Wood LLP*
Statement
Regarding Computation of Ratio of Earnings to Fixed Charges
Consent
of Sidley Austin Brown & Wood LLP
(included in Exhibit 5.1)*
Consent
of PricewaterhouseCoopers LLP, independent registered public accounting
firm for the Company
Powers
of Attorney
Statement
of Eligibility on Form T-1 of The Bank of New York as Trustee under the
Trust Indenture Act of 1939
* To be filed by amendment.
COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
(Dollars in Millions Except Per Share Amounts)
Three Months
Ended
March 31,
Year
Ended December 31,
2005
2004
2003
2002
2001
2000
$
461.0
$
2,002.4
$
2,041.9
$
1,870.3
$
1,668.7
$
1,567.2
and discount or premium
32.6
123.7
128.1
150.8
178.0
199.7
10.4
41.5
37.7
32.6
32.3
30.2
—
—
—
—
1.0
2.8
—
—
—
.6
—
—
(.8
)
(8.5
)
(.3
)
—
(.2
)
(2.2
)
$
503.2
$
2,159.1
$
2,207.4
$
2,054.3
$
1,879.8
$
1,797.7
and discount or premium
$
32.6
$
123.7
$
128.1
$
150.8
$
178.0
$
199.7
10.4
41.5
37.7
32.6
32.3
30.2
—
—
—
—
1.0
2.8
.6
2.3
4.0
7.4
14.4
3.8
$
43.6
$
167.5
$
169.8
$
190.8
$
225.7
$
236.5
11.5
12.9
13.0
10.8
8.3
7.6
July 27, 2005
Name:
/s/ Jill K. Conway
Jill K. Conway
Name:
/s/ Ronald E. Ferguson
Ronald E. Ferguson
Name:
/s/ Ellen M. Hancock
Ellen M. Hancock
Name:
/s/ David W. Johnson
David W. Johnson
Name:
/s/ Richard J. Kogan
Richard J. Kogan
Name:
/s/ Delano E. Lewis
Delano E. Lewis
Name:
/s/ Elizabeth A. Monrad
Elizabeth A. Monrad
Name:
/s/ Howard B. Wentz, Jr.
Howard B. Wentz,
Jr.
Washington, D.C. 20549
UNDER THE TRUST INDENTURE ACT OF 1939 OF A
CORPORATION DESIGNATED TO ACT AS TRUSTEE
ELIGIBILITY OF A TRUSTEE PURSUANT TO
SECTION 305(b)(2) £
(Exact name of trustee as specified in its charter)
New
York
13-5160382
(State
of incorporation
(I.R.S.
employer
if
not a U.S. national bank)
identification
no.)
One
Wall Street, New York, N.Y.
10286
(Address
of principal executive offices)
(Zip
code)
(Exact name of obligor as specified in its charter)
Delaware
13-1815595
(State
or other jurisdiction of
(I.R.S.
employer
incorporation
or organization)
identification
no.)
300
Park Avenue
New
York, New York
10022
(Address
of principal executive offices)
(Zip
code)
(Title of the indenture securities)
1.
General information. Furnish the following information as to the Trustee:
(a)
Name and address of each examining or supervising authority to which it is subject.
Name
Address
Superintendent
of Banks of the State of New York
2
Rector Street, New York, N.Y. 10006, and Albany, N.Y. 12203
Federal
Reserve Bank of New York
33
Liberty Plaza, New York, N.Y. 10045
Federal
Deposit Insurance Corporation
Washington,
D.C. 20429
New
York Clearing House Association
New
York, New York 10005
(b)
Whether it is authorized to exercise corporate trust powers.
Yes.
2.
Affiliations with Obligor.
If the obligor is an affiliate of the trustee, describe each such affiliation.
None.
16.
List of Exhibits.
Exhibits identified in parentheses below, on file with the Commission, are incorporated herein by reference as an exhibit hereto, pursuant to Rule 7a-29 under the Trust Indenture Act of 1939 (the “Act”) and 17 C.F.R. 229.10(d).
1.
A copy of the Organization Certificate of The Bank of New York (formerly Irving Trust Company) as now in effect, which contains the authority to commence business and a grant of powers to exercise corporate trust powers. (Exhibit 1 to Amendment No. 1 to Form T-1 filed with Registration Statement No. 33-6215, Exhibits 1a and 1b to Form T-1 filed with Registration Statement No. 33-21672, Exhibit 1 to Form T-1 filed with Registration Statement No. 33-29637 and Exhibit 1 to Form T-1 filed with Registration Statement No. 333-121195.)
4.
A copy of the existing By-laws of the Trustee. (Exhibit 4 to Form T-1 filed with Registration Statement No. 333-121195.)
6.
The consent of the Trustee required by Section 321(b) of the Act. (Exhibit 6 to Form T-1 filed with Registration Statement No. 333-106702.)
7.
A copy of the latest report of condition of the Trustee published pursuant to law or to the requirements of its supervising or examining authority.
Name:
BEATA HRYNIEWICKA
Title: ASSISTANT TREASURER
THE BANK OF NEW YORK
of One Wall Street, New York, N.Y. 10286
And Foreign and Domestic Subsidiaries,
Dollar
Amounts
In Thousands
$ 2,292,000
7,233,000
1,831,000
21,039,000
1,965,000
379,000
35,000
31,461,000
579,000
30,882,000
4,656,000
832,000
0
269,000
54,000
2,042,000
740,000
5,867,000
$ 80,116,000
$ 34,241,000
15,330,000
18,911,000
25,464,000
548,000
24,916,000
735,000
121,000
2,780,000
(includes mortgage indebtedness and obligations under capitalized leases)
1,560,000
55,000
1,440,000
5,803,000
$ 72,199,000
141,000
0
1,135,000
2,088,000
4,643,000
–90,000
0
7,776,000
$ 80,116,000
Thomas J. Mastro,
Senior Vice President and Comptroller
Thomas A. Renyi
Gerald L. Hassell
Alan R. Griffith
Directors